Diferencia entre revisiones de «Template:Typhoid Antibiotics»
(Created page with "'''Oral therapy with Quinolone Susceptibility:''' *Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days '''Parenteral Therapy with Quinolone Susceptibility: ''' *Ciprofloxacin 400...") |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
====Oral therapy with Quinolone Susceptibility==== | |||
*Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days | *Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days | ||
====Parenteral Therapy with Quinolone Susceptibility==== | |||
*Ciprofloxacin 400 mg IV q 12 hrs x 10 days | *Ciprofloxacin 400 mg IV q 12 hrs x 10 days | ||
====Parenteral Therapy with Quinolone Resistance==== | |||
:''if nalidixic acid resistant, assume fluoroquinolone resistant'' | :''if nalidixic acid resistant, assume fluoroquinolone resistant'' | ||
*Ceftriaxone 2mg IV q 24 hrs x 14 days | *Ceftriaxone 2mg IV q 24 hrs x 14 days | ||
::'''OR''' | ::'''OR''' | ||
*Cefixime 10-15 mg/kg IV q 12 hrs x 8 days | *Cefixime 10-15 mg/kg IV q 12 hrs x 8 days | ||
====Oral Therapy with Quinolone Resistance==== | |||
*Azithromycin 1 g PO daily x 5 days | *Azithromycin 1 g PO daily x 5 days | ||
Revisión del 15:34 12 ago 2014
Oral therapy with Quinolone Susceptibility
- Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days
Parenteral Therapy with Quinolone Susceptibility
- Ciprofloxacin 400 mg IV q 12 hrs x 10 days
Parenteral Therapy with Quinolone Resistance
- if nalidixic acid resistant, assume fluoroquinolone resistant
- Ceftriaxone 2mg IV q 24 hrs x 14 days
- OR
- Cefixime 10-15 mg/kg IV q 12 hrs x 8 days
Oral Therapy with Quinolone Resistance
- Azithromycin 1 g PO daily x 5 days